Netcompany Group A/S
Company announcement
No. 1/2021
13 January 2021
Major shareholder announcement
Netcompany Group A/S (the "Company" or "Netcompany") hereby announces the following notification received pursuant to section 38 of the Danish Capital Markets Act from Danske Bank A/S, regarding their direct and indirect holdings and voting rights in Netcompany.
Danske Bank A/S has today informed the Company, that Danske Bank A/S as of 12 January 2021 directly (0.43%) and indirectly (4.06%) via Danica Pension Livsforsikringsaktieselskab, Investeringsforeningen Danske Invest and Danske Invest SICAV in aggregate holds 2,243,959 shares, each with a nominal value of DKK1 corresponding to 4.4879% of the total share capital via and directly (0.42704%) and indirectly (4.56876%) via Danica Pension Livsforsikringsaktieselskab, Danica Pension Försäkringsaktiebolag, Investeringsforeningen Danske Invest, Kapitalforeningen Danske Invest Institutionel and Danske Invest SICAV controls 2,497,904 voting rights corresponding to 4.9958% of the total voting rights in the Company. The voting rights at the previous notification was 5.43%.
Additional information
For additional information, please contact
| Netcompany Group A/S
Thomas Johansen, CFO Tine Kosmider Boye, General Counsel |
+45 51 19 32 24 +45 24 91 75 33 |
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
